Literature DB >> 15331147

The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer's disease.

Renato Scacchi1, Giuseppe Gambina, Elisabetta Broggio, Giuseppe Moretto, Maria Ruggeri, Rosa Maria Corbo.   

Abstract

A sample of 243 Italian patients affected by the sporadic late-onset form of Alzheimer's disease (AD) was studied for the HindIII intronic polymorphism of the lipoprotein lipase (LPL) gene and compared with a sample of 148 healthy subjects. Since this polymorphism has been reported to be associated with CAD and because the two pathologies share common aspects, we decided to study it in AD too. We found a difference in the allele distribution, in that the H+ allele was more frequent in patients (0.782) than in controls (0.720); this difference was not quite significant (P = 0.059). The odds ratio from the logistic regression analysis for the H+ carrying genotypes was 2.7 (95% CI = 1.01-7.21; P = 0.048). When the separate genotypes H+H+ and H+H- were entered into the analysis, only H+H+ was found to significantly increase the risk with respect to H-H- (P = 0.029). This means that carrying this allele significantly increases the risk of developing AD, and the risk is mostly associated with the H+H+ genotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331147     DOI: 10.1016/j.neulet.2004.05.111

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  The common biological basis for common complex diseases: evidence from lipoprotein lipase gene.

Authors:  Cui Xie; Zeng Chan Wang; Xiao Feng Liu; Mao Sheng Yang
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

3.  Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population.

Authors:  Parthasaradhi Reddy Tanguturi; Bhoomireddy Pullareddy; B S Rama Krishna; Dwarkanath K Murthy
Journal:  Indian Heart J       Date:  2013-11-13

Review 4.  Lipoprotein lipase in the brain and nervous system.

Authors:  Hong Wang; Robert H Eckel
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

5.  Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance.

Authors:  Lige Leng; Ziqi Yuan; Ruiyuan Pan; Xiao Su; Han Wang; Jin Xue; Kai Zhuang; Ju Gao; Zhenlei Chen; Hui Lin; Wenting Xie; Huifang Li; Zhenyi Chen; Keke Ren; Xiao Zhang; Wenting Wang; Zi-Bing Jin; Shengxi Wu; Xinglong Wang; Zengqiang Yuan; Huaxi Xu; Hei-Man Chow; Jie Zhang
Journal:  Nat Metab       Date:  2022-10-06

6.  Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.

Authors:  Azadeh Sayad; Mehrdad Noruzinia; Mahdi Zamani; Mohammad Hossein Harirchian; Anoshirvan Kazemnejad
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

7.  Chronic sleep restriction in the rotenone Parkinson's disease model in rats reveals peripheral early-phase biomarkers.

Authors:  Juliane Fagotti; Adriano D S Targa; Lais S Rodrigues; Ana Carolina D Noseda; Flávia W C Dorieux; Franciele F Scarante; Jessica L Ilkiw; Fernando M Louzada; Namrata R Chowdhury; Daan R van der Veen; Benita Middleton; Jeroen L A Pennings; Jonathan R Swann; Debra J Skene; Marcelo M S Lima
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

Review 8.  Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk.

Authors:  Kimberley D Bruce; Maoping Tang; Philip Reigan; Robert H Eckel
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.